Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar to Announce Financial Results for the First Quarter of 2017 on Tuesday, May 9, 2017, After Close of U.S.-Based Financial Markets May 02, 2017 Nektar Therapeutics to Host Analyst & Investor Event at 2017 ASCO Annual Meeting Apr 20, 2017 Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting Apr 04, 2017 Nektar Therapeutics Initiates Clinical Study of NKTR-358, a First-in-Class Regulatory T Cell Stimulator, Being Developed for the Treatment of Immune and Inflammatory Disorders Mar 27, 2017 NKTR-181 Meets Primary and Secondary Endpoints in Phase 3 SUMMIT-07 Study in Chronic Pain Mar 20, 2017 Nektar to Webcast Presentation at Cowen and Company's 37th Annual Health Care Conference in Boston Mar 02, 2017 Nektar Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting Mar 01, 2017 Nektar Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results Mar 01, 2017 Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2016 on Wednesday, March 1, 2017, After Close of U.S.-Based Financial Markets Feb 22, 2017 Clinical Data from Phase 1 Dose-Escalation Study of Single-Agent NKTR-214 in Patients with Renal Cell Carcinoma Presented at the ASCO 2017 Genitourinary Cancers Symposium Feb 18, 2017 Pagination First page « first Previous page ‹ previous … Page 16 Page 17 Page 18 Page 19 Current page 20 Page 21 Page 22 Page 23 Page 24 … Next page next › Last page last »